| Original language | English |
|---|---|
| Pages (from-to) | 113-121 |
| Number of pages | 9 |
| Journal | American Journal of Medical Genetics Part B-neuropsychiatric Genetics |
| Volume | 180 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Mar 2019 |
Keywords
- AGE
- BDNF
- BDNF GENE
- BIPOLAR DISORDER
- CANDIDATE GENES
- NEUROTROPHIC FACTOR VAL66MET
- ONSET
- RECEPTOR
- RISK
- SCHIZOPHRENIA
- SYMPTOMS
- environmental factors
- epidemiology
- extended psychosis phenotype
- transdiagnostic psychosis phenotype
Cite this
}
Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study. / Kirli, Umut; Binbay, Tolga; Drukker, Marjan; Elbi, Hayriye; Kayahan, Bulent; Gokcelli, Duygu Keskin; Ozkinay, Ferda; Onay, Huseyin; Alptekin, Koksal; van Os, Jim.
In: American Journal of Medical Genetics Part B-neuropsychiatric Genetics, Vol. 180, No. 2, 03.2019, p. 113-121.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study
AU - Kirli, Umut
AU - Binbay, Tolga
AU - Drukker, Marjan
AU - Elbi, Hayriye
AU - Kayahan, Bulent
AU - Gokcelli, Duygu Keskin
AU - Ozkinay, Ferda
AU - Onay, Huseyin
AU - Alptekin, Koksal
AU - van Os, Jim
PY - 2019/3
Y1 - 2019/3
KW - AGE
KW - BDNF
KW - BDNF GENE
KW - BIPOLAR DISORDER
KW - CANDIDATE GENES
KW - NEUROTROPHIC FACTOR VAL66MET
KW - ONSET
KW - RECEPTOR
KW - RISK
KW - SCHIZOPHRENIA
KW - SYMPTOMS
KW - environmental factors
KW - epidemiology
KW - extended psychosis phenotype
KW - transdiagnostic psychosis phenotype
U2 - 10.1002/ajmg.b.32641
DO - 10.1002/ajmg.b.32641
M3 - Article
VL - 180
SP - 113
EP - 121
JO - American Journal of Medical Genetics Part B-neuropsychiatric Genetics
JF - American Journal of Medical Genetics Part B-neuropsychiatric Genetics
SN - 1552-4841
IS - 2
ER -